ProfileGDS5678 / 1445031_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 49% 47% 47% 50% 47% 49% 47% 47% 46% 47% 47% 47% 47% 47% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2135549
GSM967853U87-EV human glioblastoma xenograft - Control 23.1136947
GSM967854U87-EV human glioblastoma xenograft - Control 33.1228747
GSM967855U87-EV human glioblastoma xenograft - Control 43.1562650
GSM967856U87-EV human glioblastoma xenograft - Control 53.0539647
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2701849
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1715947
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0945847
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0591646
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0846747
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1075847
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0654147
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1201647
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1126947